Story perspectives
CRISPR Therapy Restores Hearing in Mice, Human Trials Ahead
8/16/2025
32 3
1 of 1
Story summary
- A study in the Journal of Clinical Investigation shows gene-editing therapy restoring hearing and balance in DFNA41 mice.
- Researchers employed CRISPR-Cas9 technology to disable a harmful mutation in the P2RX2 gene.
- The therapy demonstrated long-term benefits, indicating potential for human clinical trials for inherited hearing loss.
- Future research will assess safety and efficacy in human stem cells, targeting initial trials in a few years.
